Ph.D./ MD / MS / MDS or equivalent degree or having 3 years of research, teaching and design and development experience after MVSc / M.Pharm / ME / M.Tech with at least one research paper in Science Citation Indexed journal.
Ph.D. in Biotechnology, Biochemistry, Life Sciences, Microbiology, Chemistry, or related disciplines Development of inhibitors against FMO 3 and TMA lyases that involved in progression of atherosclerosis.
Ph.D / MD / MS / MDS or equivalent degree or having 3 years of research, teaching and design and development experience after MVSc / M.Pharm / ME / M.Tech with at least one research paper in Science Citation Indexed journal.
Doctorate (PhD/MD/MS/MDS) or equivalent degree OR having 3 years of research, teaching and design and development experience after MVSc/MPharm/ME/MTech
Masters degree in the relevant subject Genomics / Biotechnology/ Biochemistry with at least 5 years of research and clinical experience as evidenced from Fellowship / Associateship / Training/ other engagements.
Ph.D / MD / MS / MDS or equivalent degree or having 3 years of research, teaching and design and development experience after MVSc / M.Pharm / ME / M.Tech. with at least one research paper in Science Citation journal.